Role of 2',5'-oligo(adenylic acid) polymerase in the degradation of ribonucleic acid linked to double-stranded ribonucleic acid by extracts of interferon-treated cells
- PMID: 6161640
- DOI: 10.1021/bi00565a018
Role of 2',5'-oligo(adenylic acid) polymerase in the degradation of ribonucleic acid linked to double-stranded ribonucleic acid by extracts of interferon-treated cells
Abstract
RNA covalently linked to double-stranded RNA (dsRNA) is preferentially degraded in extracts of interferon-treated HeLa cells [Nilsen, T. W., & Baglioni, C. (1979) Proc. Natl. Acad. Sci. U.S.A. 76, 2600-2604]. The size of the dsRNA required for this preferential degradation has been determined by annealing poly(I) of known length to the poly(C) tract of encephalomyocarditis virus (EMCV) RNA or by annealing poly(U) to poly(A) of known length of vesicular stomatitis virus mRNA. The dsRNA must be longer than about 60 base pairs to observe the preferential degradation of RNA. Moreover, triple-stranded regions that do not activate synthesis of 2',5'-oligo(A) and ethidium bromide, which intercalates in dsRNA and blocks 2',5'-olido(A) polymerase activation, prevent this degradation. Ethidium also blocks the degradation of the replicative intermediate of EMCV by extracts of interferon-treated cells. These experiments indicate that synthesis of 2',5'-oligo(A) is required for the degradation of RNA linked to dsRNA. The 2',5'-oligo(A)-dependent endonuclease does not cleave single- or double-stranded DNA, nor does it cleave homopolyribonucleotides. The potential role of the 2',5'-oligo(A) polymerase/endonuclease system in the inhibition of viral RNA replication is discussed.
Similar articles
-
Inhibition of double-stranded ribonucleic acid activated protein kinase and 2',5'-oligo(adenylic acid) polymerase by ethidium bromide.Biochemistry. 1981 Feb 17;20(4):758-62. doi: 10.1021/bi00507a016. Biochemistry. 1981. PMID: 6163449
-
Mechanism for discrimination between viral and host mRNA in interferon-treated cells.Proc Natl Acad Sci U S A. 1979 Jun;76(6):2600-4. doi: 10.1073/pnas.76.6.2600. Proc Natl Acad Sci U S A. 1979. PMID: 223150 Free PMC article.
-
2'5' oligo(A) polymerase activity in serum of mice infected with EMC virus or treated with interferon.Nature. 1980 Jun 12;285(5765):485-8. doi: 10.1038/285485a0. Nature. 1980. PMID: 6157092
-
[Antiviral action of interferon (author's transl)].Seikagaku. 1980;52(2):98-102. Seikagaku. 1980. PMID: 6159431 Review. Japanese. No abstract available.
-
Molecular mechanisms of action of interferon.Tex Rep Biol Med. 1981-1982;41:471-8. Tex Rep Biol Med. 1981. PMID: 6189211 Review. No abstract available.
Cited by
-
Cleavage of nascent reovirus mRNA by localized activation of the 2'-5'-oligoadenylate-dependent endoribonuclease.J Virol. 1984 Dec;52(3):865-71. doi: 10.1128/JVI.52.3.865-871.1984. J Virol. 1984. PMID: 6208382 Free PMC article.
-
Cyclic AMP-dependent regulation of activities of synthetase and phosphodiesterase of 2',5'-oligoadenylate in NIH 3T3 cells.Mol Cell Biochem. 1984;58(1-2):165-71. doi: 10.1007/BF00240616. Mol Cell Biochem. 1984. PMID: 6323957
-
Mechanisms employed by retroviruses to exploit host factors for translational control of a complicated proteome.Retrovirology. 2009 Jan 24;6:8. doi: 10.1186/1742-4690-6-8. Retrovirology. 2009. PMID: 19166625 Free PMC article. Review.
-
RNase L restricts the mobility of engineered retrotransposons in cultured human cells.Nucleic Acids Res. 2014 Apr;42(6):3803-20. doi: 10.1093/nar/gkt1308. Epub 2013 Dec 25. Nucleic Acids Res. 2014. PMID: 24371271 Free PMC article.
-
The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.Pharmacol Ther. 1998 May;78(2):55-113. doi: 10.1016/s0163-7258(97)00167-8. Pharmacol Ther. 1998. PMID: 9623881 Free PMC article. Review.